• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Evolv Technology Reports First Quarter Financial Results

    5/12/26 4:05:00 PM ET
    $EVLV
    Computer peripheral equipment
    Technology
    Get the next $EVLV alert in real time by email

    — Company Raises Outlook for 2026 —

    • Q1'26 Revenue of $46.3 million, up 45% year-over-year
    • Q1'26 Ending ARR1 of $127.3 million, up 20% year-over-year
    • Q1'26 Net Loss of $(5.0) million, with Net Profit Margin of (10.8)%
    • Q1'26 Adjusted EBITDA2 of $3.9 million, with Adjusted EBITDA Margin2 of 8.5%

    Evolv Technologies Holdings, Inc (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced financial results for the quarter ended March 31, 2026.

    "Our first quarter results reflect our progress in building a disciplined and predictable business," said John Kedzierski, President and Chief Executive Officer of Evolv Technology. "Revenue growth during the quarter was driven by new customer acquisition, expanding deployments within our installed base, and growing adoption of our newest product — Evolv eXpedite. Looking ahead, we remain focused on scaling the business and delivering weapon screening in complex, real-world environments across the growing customer base we are serving—helping make the world a better place to live, learn, work, and play."

    Results for the First Quarter of 2026

    Total revenue for the first quarter of 2026 was $46.3 million, an increase of 45% compared to $32.0 million for the first quarter of 2025. Revenue for the first quarter of 2026 was primarily driven by strong new customer additions and continued expansion of deployments across the existing customer base. Annual Recurring Revenue ("ARR")1 was $127.3 million at the end of first quarter of 2026, an increase of 20% compared to $106.0 million at the end of the first quarter of 2025. Net loss for the first quarter of 2026 was $(5.0) million, or $(0.03) per basic and diluted share, compared to net loss of $(1.7) million, or $(0.01) per basic and diluted share, in the first quarter of 2025. Adjusted loss2 for the first quarter of 2026 was $(3.3) million, or $(0.02) per diluted share, compared to adjusted loss2 of $(3.4) million, or $(0.02) per diluted share, for the first quarter of 2025. Adjusted EBITDA2 for the first quarter of 2026 was $3.9 million compared to $2.1 million in the first quarter of 2025. As of March 31, 2026, the Company had cash, cash equivalents and marketable securities of $61.1 million.

    The following table summarizes the breakdown of recurring and non-recurring revenue3 for each period presented:

     

    Three Months Ended

    March 31,

     

     

    2026

     

     

     

    2025

     

     

    % Change

    Recurring revenue

    $

    31,176

     

    $

    25,753

     

    21

    %

    Non-recurring revenue

     

    15,152

     

     

    6,254

     

    142

    %

    Total revenue

    $

    46,328

     

    $

    32,007

     

    45

    %

    The following table summarizes operating cash flows for each period presented:

     

    Three Months Ended

    March 31,

     

     

    2026

     

     

     

    2025

     

    Net loss

    $

    (5,009

    )

     

    $

    (1,689

    )

    Adjustments to reconcile net loss to net cash used in operating activities

     

    9,604

     

     

     

    (1,082

    )

    Changes in operating assets and liabilities

     

    (7,774

    )

     

     

    232

     

    Net cash used in operating activities

    $

    (3,179

    )

     

    $

    (2,539

    )

    Company Comments on Outlook for 2026

    The Company today commented on its business outlook for 2026. The Company's outlook is based on the current indications for its business, which may change at any time. The Company expects total revenues in 2026 to be between $175 to $180 million, reflecting growth of approximately 20% to 23% year-over-year. The Company expects ending ARR at December 31, 2026 to increase to approximately $145 to $150 million, reflecting growth of approximately 20% to 25% year-over-year. The Company currently expects approximately 45% of the Company's new unit deployments in 2026 to be delivered under the Company's pure subscription model, with the remaining 55% deployed through the Company's purchase-subscription model. The Company expects to deliver positive full year Adjusted EBITDA1 in 2026 with Adjusted EBITDA1 margins in the high single digits.

    Estimate

     

    Issued March 10, 2026

     

    Issued May 12, 2026

    Total Revenue (Millions)

     

    $172-$178

     

    $175-$180

    Ending ARR at 12/31/26 (Millions)

     

    $145-$150

     

    No Change

    Adjusted EBITDA Margin2

     

    High Single Digits

     

    No Change

    Company to Host Live Conference Call and Webcast

    The Company's management team plans to host a live conference call and webcast at 4:30 p.m. Eastern Time today to discuss the financial results as well as management's outlook for the business. The conference call will be webcast live at http://ir.evolvtechnology.com.

    About Evolv Technology

    Evolv Technologies Holdings, Inc (NASDAQ:EVLV) is designed to transform human security to make a safer, faster, and better experience for the world's most iconic venues and companies as well as schools, hospitals, and public spaces, using industry leading artificial intelligence (AI)-powered screening and analytics. Its mission is to transform security to create a safer world to live, work, learn, and play. Evolv has digitally transformed the gateways in many places where people gather by enabling seamless integration combined with powerful analytics and insights. Evolv's advanced systems have scanned more than four billion people since 2019. Evolv has been awarded the U.S. Department of Homeland Security (DHS) SAFETY Act Designation as a Qualified Anti-Terrorism Technology (QATT) as well as the Security Industry Association (SIA) 2024 New Products and Solutions (NPS) Award in the Law Enforcement/Public Safety/Guarding Systems category, as well as Sport Business Journal's (SBJ) 2024 awards for "Best In Fan Experience Technology" and "Best In Sports Technology". Evolv®, Evolv Express®, Evolv Insights®, Evolv Visual Gun Detection™, Evolv eXpedite™, and Evolv Eva™ are registered trademarks or trademarks of Evolv Technologies, Inc. in the United States and other jurisdictions. For more information, visit evolv.com.

    1 We define Annual Recurring Revenue, or ARR, as the sum of subscription revenue and the recurring service revenue related to purchase subscriptions for the final month of the quarter all multiplied by twelve. The amount of revenue that we recognize over any 12-month period is likely to differ from ARR at the beginning of that period, sometimes significantly due to differences in our recurring and non-recurring revenue streams. To the extent that we are negotiating a renewal or upgrade with a customer after the expiration of the subscription and we are continuing to provide service to that customer, we may continue to include that associated revenue in ARR. If a customer notifies us that it is not renewing its subscription, we will continue to include associated revenue in ARR through the natural expiration of the subscription term. ARR should be viewed independently of, and not as a substitute for or forecast of, revenue or deferred revenue. Our calculation of ARR may differ from similarly titled metrics presented by other companies.

    2 Non-GAAP Financial Measures In this press release, the Company's adjusted operating expenses, adjusted gross profit (loss), adjusted gross margin, adjusted operating income (loss), adjusted EBITDA, adjusted EBITDA margin, adjusted earnings (loss), and adjusted earnings (loss) per diluted share are not presented in accordance with generally accepted accounting principles (GAAP) and are not intended to be used in lieu of GAAP presentations of results of operations. Adjusted operating expenses is defined as operating expenses less stock-based compensation expense, non-recurring employee restructuring and other separation costs, and other non-recurring legal and regulatory costs, which management believes provides a more meaningful representation of on-going operating expense levels. Other non-recurring legal and regulatory costs include non-recurring legal, accounting and professional fees related to the internal investigation, subsequent restatement, certain non-recurring regulatory, litigation and legal matters, as well as fees related to the resolution of the Securities and Exchange Commission investigation, net of estimated insurance recoveries. Adjusted gross profit and adjusted gross margin exclude stock-based compensation expense and amortization of capitalized stock-based compensation, which management believes provides a more meaningful representation of contribution margin. Adjusted operating income (loss) is defined as loss from operations, excluding stock-based compensation expense, amortization of capitalized stock-based compensation, non-recurring employee restructuring and other separation costs, and other non-recurring legal and regulatory costs, which management believes provides a more meaningful representation of operating results. Adjusted EBITDA and Adjusted EBITDA margin is defined as net income (loss) plus depreciation and amortization, stock-based compensation, interest expense (income), (benefit) provision for income taxes, change in fair value of contingent earn-out liability, change in fair value of contingently issuable/returnable common stock liability/asset, change in fair value of public warrant liability, loss on disposal of leased equipment, non-recurring employee restructuring and other separation costs, and other non-recurring legal and regulatory costs, which management believes provides a more meaningful representation of operating results. Adjusted earnings (loss) and Adjusted earnings (loss) per diluted share are defined as net income (loss) plus stock-based compensation, amortization of capitalized stock-based compensation, change in fair value of contingent earn-out liability, change in fair value of contingently issuable/returnable common stock liability/asset, change in fair value of public warrant liability, non-recurring employee restructuring and other separation costs, and other non-recurring legal and regulatory costs, which management believes provides a more meaningful representation of operating results. Management presents non-GAAP financial measures because it considers them to be important supplemental measures of performance. Management uses non-GAAP financial measures for planning purposes, including analysis of the Company's performance against prior periods, the preparation of operating budgets and to determine appropriate levels of operating and capital investments. Management also believes non-GAAP financial measures provide additional insight for analysts and investors in evaluating the Company's financial and operating performance. However, non-GAAP financial measures have limitations as an analytical tool and are not intended to be an alternative to financial measures prepared in accordance with GAAP. We intend to provide non-GAAP financial measures as part of our future earnings discussions and, therefore, the inclusion of non-GAAP financial measures will provide consistency in our financial reporting. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures included in this press release. The Company is unable to provide a reconciliation of Adjusted EBITDA to Net Income (Loss) and Adjusted EBITDA Margin to Net Profit Margin, each measure's most directly comparable GAAP financial measure, on a forward-looking basis without unreasonable effort, because items that impact these GAAP financial measures are not within the Company's control and/or cannot be reasonably predicted. These items may include, but are not limited to, predicting forward-looking share-based compensation, changes in the fair value of contingent earn out liabilities, changes in the fair value of contingently issuable/returnable common stock liabilities/assets, and changes in fair value of public warrant liabilities. Such information may have a significant, and potentially unpredictable, impact on the Company's future financial results.

    3 Recurring revenue includes the recurring portion of revenue associated with pure subscription contracts and hardware purchase subscription contracts. Non-recurring revenue includes revenue that is non-recurring in nature, such as product revenue, shipping revenue, revenue from installation, training, and professional services, and rental revenue.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this press release and related presentation materials other than statements of historical facts, including without limitation statements regarding our strategy, goals, business model, demand for our products, market opportunities, strategic partnerships, and future financial and operational results. Words such as "believe," "may," "will," "expect," "should," "could," "anticipate," "aim," "estimate," "intend," "plan," "potential," "continue," "project," "target," "forecast," "is/are likely to," or the negative of these terms or other similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. The forward-looking statements in this press release and related presentation materials are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the amount of insurance reimbursements expected to be received for defense costs for counsel and consultants in connection with the securities litigation and related Securities and Exchange Commission (the "SEC") and Department of Justice matters, and the following: our history of losses and ability to reach profitability; our reliance on reseller partners; expectations regarding the Company's strategies and future financial performance, including its future business plans or objectives, prospective performance and opportunities and competitors, revenues, products and services, pricing, operating expenses, market trends, liquidity, cash flows and uses of cash, capital expenditures; our ability to renew customer contracts, our ability to renew customer contracts at terms favorable to the Company, the Company's reliance on third party contract manufacturing and distribution, and a global supply chain; the Company recognizes a substantial portion of its revenue ratably over the term of its agreements, and, as a result, downturns or upturns in sales may not be immediately reflected in its operating results; the rate of innovation required to maintain competitiveness in the markets in which the Company competes; the competitiveness of the market in which the Company competes; the failure of our products to detect threats could result in injury or loss of life, which could harm our brand, reputation, and results of operations; the loss of designation of our Evolv Express® system as a Qualified Anti-Terrorism Technology under the Homeland Security SAFETY Act; risks related to our business model, which is predicated, in part, on building a customer base that will generate a recurring stream of revenues through the sale of our subscription contracts; the ability for the Company to obtain, maintain, protect and enforce the Company's intellectual property rights and use of "open source" software; the concentration of the Company's revenues on a single solution; the Company's ability to timely design, produce and launch its solutions, the Company's ability to invest in growth initiatives and pursue acquisition opportunities; the limited liquidity and trading of the Company's securities; risks related to existing and changing tax laws; geopolitical risk and changes in applicable laws or regulations; the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors; operational risk; risks related to material weaknesses in our internal control over financial reporting and our remediation plans and efforts, including related costs; risks related to increasing attention to and evolving expectations for sustainability initiatives; the impact of fluctuating general economic and market conditions and reductions in spending; the need for additional capital to support business growth, which might not be available on acceptable terms, if at all; and litigation and regulatory enforcement risks, including the diversion of management time and attention and the additional costs and demands on resources. These and other important factors discussed in our most recent report on Form 10-Q or 10-K filed with the SEC could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. The forward-looking statements in this press release and related presentation materials are based upon information available to us as of the date hereof, and while we believe such information forms a reasonable basis for such statements, it may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.

    You should review this press release and the documents that we reference in this press release and related presentation materials with the understanding that our actual future results, levels of activity, performance and achievements may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained in this press release and related presentation materials, whether as a result of any new information, future events or otherwise.

    EVOLV TECHNOLOGY

    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

    (In thousands, except share and per share data)

    (Unaudited)

     

     

     

     

     

    Three Months Ended

    March 31,

     

     

     

    2026

     

     

     

    2025

     

    Revenue:

     

     

     

    Product revenue

    $

    13,421

     

     

    $

    2,322

     

    Subscription revenue

     

    23,148

     

     

     

    19,237

     

    Service revenue

     

    8,589

     

     

     

    6,730

     

    License fee and other revenue

     

    1,170

     

     

     

    3,718

     

    Total revenue

     

    46,328

     

     

     

    32,007

     

    Cost of revenue:

     

     

     

    Cost of product revenue

     

    11,856

     

     

     

    3,184

     

    Cost of subscription revenue

     

    8,367

     

     

     

    7,896

     

    Cost of service revenue

     

    2,192

     

     

     

    1,705

     

    Cost of license fee and other revenue

     

    314

     

     

     

    72

     

    Total cost of revenue

     

    22,729

     

     

     

    12,857

     

    Gross profit

     

    23,599

     

     

     

    19,150

     

    Operating expenses:

     

     

     

    Research and development

     

    5,885

     

     

     

    4,862

     

    Sales and marketing

     

    12,671

     

     

     

    11,043

     

    General and administrative

     

    13,515

     

     

     

    14,972

     

    Restructuring costs

     

    —

     

     

     

    2,662

     

    Total operating expenses

     

    32,071

     

     

     

    33,539

     

    Loss from operations

     

    (8,472

    )

     

     

    (14,389

    )

    Other income, net

     

     

     

    Interest expense

     

    (962

    )

     

     

    (1

    )

    Interest income

     

    515

     

     

     

    389

     

    Other income (expense), net

     

    (37

    )

     

     

    25

     

    Change in fair value of contingent earn-out liability

     

    374

     

     

     

    8,976

     

    Change in fair value of contingently issuable/returnable common stock liability/asset

     

    1,492

     

     

     

    1,653

     

    Change in fair value of public warrant liability

     

    2,044

     

     

     

    1,721

     

    Total other income, net

     

    3,426

     

     

     

    12,763

     

    Loss before income taxes

     

    (5,046

    )

     

     

    (1,626

    )

    (Benefit) provision for income taxes

     

    (37

    )

     

     

    63

     

    Net loss

    $

    (5,009

    )

     

    $

    (1,689

    )

    Net loss attributable to common stockholders – basic and diluted

    $

    (5,009

    )

     

    $

    (1,689

    )

     

     

     

     

    Weighted average common shares outstanding – basic and diluted

     

    177,057,656

     

     

     

    160,808,391

     

    Net loss per share – basic and diluted

    $

    (0.03

    )

     

    $

    (0.01

    )

     

     

     

     

    Net income (loss)

    $

    (5,009

    )

     

    $

    (1,689

    )

    Other comprehensive income (loss)

     

     

     

    Cumulative translation adjustment

     

    28

     

     

     

    (46

    )

    Total other comprehensive income (loss)

     

    28

     

     

     

    (46

    )

    Total comprehensive loss

    $

    (4,981

    )

     

    $

    (1,735

    )

    EVOLV TECHNOLOGY

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (In thousands, except share and per share data)

    (Unaudited)

     

     

    March 31, 2026

     

    December 31, 2025

    Assets

     

     

     

    Current assets:

     

     

     

    Cash and cash equivalents

    $

    56,081

     

     

    $

    49,150

     

    Marketable securities

     

    4,992

     

     

     

    19,885

     

    Accounts receivable, net

     

    42,713

     

     

     

    30,841

     

    Inventory

     

    8,256

     

     

     

    9,317

     

    Current portion of contract assets

     

    1,199

     

     

     

    878

     

    Current portion of commission asset

     

    5,644

     

     

     

    6,062

     

    Prepaid expenses and other current assets

     

    33,094

     

     

     

    35,169

     

    Total current assets

     

    151,979

     

     

     

    151,302

     

    Contract assets, noncurrent

     

    12

     

     

     

    15

     

    Commission asset, noncurrent

     

    7,728

     

     

     

    7,867

     

    Property and equipment, net

     

    127,839

     

     

     

    127,522

     

    Operating lease right-of-use assets

     

    11,871

     

     

     

    12,303

     

    Other assets

     

    5,210

     

     

     

    5,400

     

    Total assets

    $

    304,639

     

     

    $

    304,409

     

     

     

     

     

    Liabilities and Stockholders' Equity

     

     

     

    Current liabilities:

     

     

     

    Accounts payable

    $

    17,089

     

     

    $

    9,770

     

    Accrued expenses and other current liabilities

     

    30,345

     

     

     

    35,293

     

    Current portion of deferred revenue

     

    75,314

     

     

     

    74,924

     

    Current portion of operating lease liabilities

     

    3,116

     

     

     

    2,989

     

    Total current liabilities

     

    125,864

     

     

     

    122,976

     

    Deferred revenue, noncurrent

     

    17,036

     

     

     

    16,716

     

    Long-term debt

     

    28,665

     

     

     

    28,596

     

    Operating lease liabilities, noncurrent

     

    10,190

     

     

     

    10,654

     

    Contingent earn-out liability, noncurrent

     

    —

     

     

     

    374

     

    Contingently issuable common stock liability, noncurrent

     

    392

     

     

     

    1,809

     

    Public warrant liability, noncurrent

     

    1,818

     

     

     

    3,862

     

    Total liabilities

     

    183,965

     

     

     

    184,987

     

     

     

     

     

    Stockholders' equity:

     

     

     

    Preferred stock, $0.0001 par value; 100,000,000 authorized at March 31, 2026 and December 31, 2025; no shares issued and outstanding at March 31, 2026 and December 31, 2025

     

    —

     

     

     

    —

     

    Common stock, $0.0001 par value; 1,100,000,000 shares authorized at March 31, 2026 and December 31, 2025; 179,458,233 and 175,399,488 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively

     

    18

     

     

     

    18

     

    Additional paid-in capital

     

    513,580

     

     

     

    507,347

     

    Accumulated other comprehensive loss

     

    (113

    )

     

     

    (141

    )

    Accumulated deficit

     

    (392,811

    )

     

     

    (387,802

    )

    Stockholders' equity

     

    120,674

     

     

     

    119,422

     

    Total liabilities and stockholders' equity

    $

    304,639

     

     

    $

    304,409

     

    EVOLV TECHNOLOGY

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (In thousands)

    (Unaudited)

     

     

     

     

     

    Three Months Ended

    March 31,

     

     

     

    2026

     

     

     

    2025

     

    Cash flows from operating activities:

     

     

     

    Net loss

    $

    (5,009

    )

     

    $

    (1,689

    )

    Adjustments to reconcile net loss to net cash used in operating activities:

     

     

     

    Depreciation and amortization

     

    6,801

     

     

     

    5,530

     

    Write-off of inventory and change in inventory reserve

     

    60

     

     

     

    2

     

    Loss on disposal of property and equipment

     

    184

     

     

     

    321

     

    Stock-based compensation

     

    5,587

     

     

     

    4,879

     

    Amortization of debt issuance costs

     

    282

     

     

     

    —

     

    Amortization of premium on marketable securities, net of change in accrued interest

     

    168

     

     

     

    71

     

    Non-cash lease expense

     

    432

     

     

     

    424

     

    Change in allowance for expected credit losses

     

    —

     

     

     

    41

     

    Change in fair value of earn-out liability

     

    (374

    )

     

     

    (8,976

    )

    Change in fair value of contingently issuable/returnable common stock liability/asset

     

    (1,492

    )

     

     

    (1,653

    )

    Change in fair value of public warrant liability

     

    (2,044

    )

     

     

    (1,721

    )

    Changes in operating assets and liabilities

     

     

     

    Accounts receivable

     

    (11,872

    )

     

     

    (6,124

    )

    Inventory

     

    1,657

     

     

     

    7,172

     

    Commission assets

     

    557

     

     

     

    203

     

    Contract assets

     

    (318

    )

     

     

    (321

    )

    Other assets

     

    265

     

     

     

    82

     

    Prepaid expenses and other current assets

     

    (1,883

    )

     

     

    (3,859

    )

    Accounts payable

     

    7,614

     

     

     

    2,780

     

    Deferred revenue

     

    710

     

     

     

    500

     

    Accrued expenses and other current liabilities

     

    (4,167

    )

     

     

    (71

    )

    Operating lease liability

     

    (337

    )

     

     

    (130

    )

    Net cash used in operating activities

     

    (3,179

    )

     

     

    (2,539

    )

    Cash flows from investing activities:

     

     

     

    Development of internal-use software

     

    (1,223

    )

     

     

    (1,556

    )

    Purchases of property and equipment

     

    (3,742

    )

     

     

    (12,730

    )

    Purchases of marketable securities

     

    —

     

     

     

    (9,875

    )

    Proceeds from maturities of marketable securities

     

    14,725

     

     

     

    14,800

     

    Net cash provided by (used in) investing activities

     

    9,760

     

     

     

    (9,361

    )

    Cash flows from financing activities:

     

     

     

    Proceeds from exercise of stock options

     

    322

     

     

     

    20

     

    Net cash provided by financing activities

     

    322

     

     

     

    20

     

    Effect of exchange rate changes on cash and cash equivalents

     

    28

     

     

     

    (46

    )

    Net increase (decrease) in cash and cash equivalents

     

    6,931

     

     

     

    (11,926

    )

    Cash and cash equivalents

     

     

     

    Cash and cash equivalents at beginning of period

     

    49,150

     

     

     

    37,015

     

    Cash and cash equivalents at end of period

    $

    56,081

     

     

    $

    25,089

     

    EVOLV TECHNOLOGY

    SUMMARY OF KEY OPERATING STATISTICS

    (Unaudited)

     

     

     

     

     

    Three Months Ended or as of,

    ($ in thousands)

     

    March 31,

    2025

     

    June 30,

    2025

     

    September 30,

    2025

     

    December 31,

    2025

     

    March 31,

    2026

    New customers

     

    54

     

     

    63

     

     

    62

     

     

    64

     

     

    48

    Annual recurring revenue

    $

    105,990

     

    $

    110,516

     

    $

    117,200

     

    $

    120,467

     

    $

    127,300

    Recurring revenue

    $

    25,753

     

    $

    26,678

     

    $

    30,120

     

    $

    29,547

     

    $

    31,176

    EVOLV TECHNOLOGY

    RECONCILIATION OF GAAP OPERATING EXPENSES TO ADJUSTED OPERATING EXPENSES

    (In thousands)

    (Unaudited)

     

     

     

     

     

    Three Months Ended,

     

     

    March 31,

    2025

     

    June 30,

    2025

     

    September 30,

    2025

     

    December 31,

    2025

     

    March 31,

    2026

    Operating expenses, GAAP

    $

    33,539

     

     

    $

    33,711

     

     

    $

    29,902

     

     

    $

    26,613

     

     

    $

    32,071

     

    Stock-based compensation

     

    (4,660

    )

     

     

    (5,265

    )

     

     

    (5,121

    )

     

     

    (5,006

    )

     

     

    (5,272

    )

    Non-recurring employee restructuring and other separation costs

     

    (2,137

    )

     

     

    (827

    )

     

     

    (6

    )

     

     

    —

     

     

     

    —

     

    Other non-recurring legal and regulatory costs

     

    (3,561

    )

     

     

    (5,979

    )

     

     

    36

     

     

     

    2,225

     

     

     

    99

     

    Adjusted operating expenses

    $

    23,181

     

     

    $

    21,640

     

     

    $

    24,811

     

     

    $

    23,832

     

     

    $

    26,898

     

    EVOLV TECHNOLOGY

    RECONCILIATION OF GAAP GROSS PROFIT TO ADJUSTED GROSS PROFIT, GAAP GROSS MARGIN TO ADJUSTED GROSS MARGIN AND GAAP INCOME (LOSS) FROM OPERATIONS TO ADJUSTED OPERATING INCOME (LOSS)

    (In thousands)

    (Unaudited)

     

     

    Three Months Ended

    March 31,

     

     

    2026

     

     

     

    2025

     

    Revenue

    $

    46,328

     

     

    $

    32,007

     

    Cost of revenue

     

    22,729

     

     

     

    12,857

     

    Gross profit, GAAP

     

    23,599

     

     

     

    19,150

     

    Stock-based compensation

     

    315

     

     

     

    219

     

    Amortization of capitalized stock-based compensation

     

    161

     

     

     

    103

     

    Adjusted gross profit

    $

    24,075

     

     

    $

    19,472

     

     

     

     

     

    Gross margin %

     

    50.9

    %

     

     

    59.8

    %

    Impact of adjustments from Gross profit, GAAP to Adjusted gross profit

     

    1.1

    %

     

     

    1.0

    %

    Adjusted gross margin %

     

    52.0

    %

     

     

    60.8

    %

     

     

    Three Months Ended

    March 31,

     

     

    2026

     

     

     

    2025

     

    Loss from operations, GAAP

    $

    (8,472

    )

     

    $

    (14,389

    )

    Stock-based compensation

     

    5,587

     

     

     

    4,879

     

    Amortization of capitalized stock-based compensation

     

    161

     

     

     

    103

     

    Non-recurring employee restructuring and other separation costs

     

    —

     

     

     

    2,137

     

    Other non-recurring legal and regulatory costs

     

    (99

    )

     

     

    3,561

     

    Adjusted loss from operations

    $

    (2,823

    )

     

    $

    (3,709

    )

    EVOLV TECHNOLOGY

    RECONCILIATION OF GAAP NET INCOME (LOSS) TO ADJUSTED EBITDA AND NET PROFIT MARGIN TO ADJUSTED EBITDA MARGIN

    (In thousands)

    (Unaudited)

     

     

     

     

     

    Three Months Ended

    March 31,

     

     

     

    2026

     

     

     

    2025

     

    Net loss

    $

    (5,009

    )

     

    $

    (1,689

    )

    Depreciation and amortization

     

    6,801

     

     

     

    5,530

     

    Stock-based compensation

     

    5,587

     

     

     

    4,879

     

    Interest expense (income)

     

    447

     

     

     

    (388

    )

    (Benefit) provision for income taxes

     

    (37

    )

     

     

    63

     

    Change in fair value of contingent earn-out liability

     

    (374

    )

     

     

    (8,976

    )

    Change in fair value of contingently issuable/returnable common stock liability/asset

     

    (1,492

    )

     

     

    (1,653

    )

    Change in fair value of public warrant liability

     

    (2,044

    )

     

     

    (1,721

    )

    Loss on disposal of leased equipment*

     

    164

     

     

     

    321

     

    Non-recurring employee restructuring and other separation costs

     

    —

     

     

     

    2,137

     

    Other non-recurring legal and regulatory costs

     

    (99

    )

     

     

    3,561

     

    Adjusted EBITDA

    $

    3,944

     

     

    $

    2,064

     

     

     

     

     

    Net profit margin %

     

    (10.8

    )%

     

     

    (5.3

    )%

    Impact of adjustments from Net loss to Adjusted EBITDA

     

    19.3

    %

     

     

    11.7

    %

    Adjusted EBITDA margin %

     

    8.5

    %

     

     

    6.4

    %

     

    *Q1 2025 figure reflects refinements of our adjusted EBITDA calculation in Q3 2025, applied consistently to all prior quarters.

    EVOLV TECHNOLOGY

    RECONCILIATION OF GAAP NET INCOME (LOSS) TO ADJUSTED EARNINGS (LOSS)

    (In thousands, except share and per share data)

    (Unaudited)

     

     

     

     

     

    Three Months Ended

    March 31,

     

     

     

    2026

     

     

     

    2025

     

    Net loss

    $

    (5,009

    )

     

    $

    (1,689

    )

    Stock-based compensation

     

    5,587

     

     

     

    4,879

     

    Amortization of capitalized stock-based compensation

     

    161

     

     

     

    103

     

    Change in fair value of contingent earn-out liability

     

    (374

    )

     

     

    (8,976

    )

    Change in fair value of contingently issuable/returnable common stock liability/asset

     

    (1,492

    )

     

     

    (1,653

    )

    Change in fair value of public warrant liability

     

    (2,044

    )

     

     

    (1,721

    )

    Non-recurring employee restructuring and other separation costs

     

    —

     

     

     

    2,137

     

    Other non-recurring legal and regulatory costs

     

    (99

    )

     

     

    3,561

     

    Adjusted loss

    $

    (3,270

    )

     

    $

    (3,359

    )

     

     

     

     

    Weighted average common shares outstanding – diluted

     

    177,057,656

     

     

     

    160,808,391

     

     

     

     

     

    Net loss per share – diluted

    $

    (0.03

    )

     

    $

    (0.01

    )

    Impact of adjustments from Net loss to Adjusted loss

     

    0.01

     

     

     

    (0.01

    )

    Adjusted loss per share – diluted

    $

    (0.02

    )

     

    $

    (0.02

    )

     

    Three Months Ended,

     

    March 31,

    2025

     

    June 30,

    2025

     

    September 30,

    2025

     

    December 31,

    2025

     

    March 31,

    2026

    Stock-based compensation:

     

     

     

     

     

     

     

     

     

    Cost of product revenue

    $

    8

     

    $

    17

     

    $

    32

     

    $

    39

     

    $

    58

    Cost of subscription revenue

     

    137

     

     

    167

     

     

    146

     

     

    135

     

     

    138

    Cost of service revenue

     

    67

     

     

    74

     

     

    72

     

     

    80

     

     

    100

    Cost of license fee and other revenue

     

    7

     

     

    24

     

     

    19

     

     

    20

     

     

    19

    Research and development

     

    1,115

     

     

    1,154

     

     

    1,227

     

     

    1,252

     

     

    1,280

    Sales and marketing

     

    1,048

     

     

    1,710

     

     

    1,480

     

     

    1,330

     

     

    1,566

    General and administrative

     

    1,972

     

     

    2,401

     

     

    2,414

     

     

    2,424

     

     

    2,426

    Restructuring costs

     

    525

     

     

    —

     

     

    —

     

     

    —

     

     

    —

    Total stock-based compensation

    $

    4,879

     

    $

    5,547

     

    $

    5,390

     

    $

    5,280

     

    $

    5,587

     

     

     

     

     

     

     

     

     

     

    Amortization of capitalized stock-based compensation:

     

     

     

     

     

     

     

     

     

    Cost of subscription revenue

    $

    59

     

    $

    60

     

    $

    63

     

    $

    82

     

    $

    86

    Cost of service revenue

     

    44

     

     

    47

     

     

    51

     

     

    68

     

     

    75

    Total amortization of capitalized stock-based compensation

    $

    103

     

    $

    107

     

    $

    114

     

    $

    150

     

    $

    161

     

     

     

     

     

     

     

     

     

     

    Non-recurring employee restructuring and other separation costs:

     

     

     

     

     

     

     

     

     

    Cost of service revenue

    $

    —

     

    $

    6

     

    $

    —

     

    $

    —

     

    $

    —

    Research and development

     

    —

     

     

    31

     

     

    —

     

     

    —

     

     

    —

    Sales and marketing

     

    —

     

     

    613

     

     

    6

     

     

    —

     

     

    —

    General and administrative

     

    —

     

     

    183

     

     

    —

     

     

    —

     

     

    —

    Restructuring costs

     

    2,137

     

     

    —

     

     

    —

     

     

    —

     

     

    —

    Total non-recurring employee restructuring and other separation costs

    $

    2,137

     

    $

    833

     

    $

    6

     

    $

    —

     

    $

    —

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260512266569/en/

    Investor Relations:

    Brian Norris

    Senior Vice President of Finance and Investor Relations

    bnorris@evolvtechnology.com

    Get the next $EVLV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $EVLV

    DatePrice TargetRatingAnalyst
    8/15/2025$9.00Hold → Buy
    Lake Street
    8/15/2025$10.00Buy
    TD Cowen
    5/21/2025$7.50Market Perform → Outperform
    Northland Capital
    10/28/2024Outperform → Market Perform
    Northland Capital
    5/20/2024$8.50 → $5.75Buy
    Craig Hallum
    5/10/2024$6.00 → $3.50Buy → Hold
    Lake Street
    11/21/2023$6.00Buy
    Lake Street
    4/28/2023$6.00Buy
    Craig Hallum
    More analyst ratings

    $EVLV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Evolv Technology to Host Investor Day on June 9, 2026

    Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced that it will host Evolv Technology Investor Day 2026 on Tuesday, June 9, 2026 from 9:00 a.m. to 12:00 p.m. Eastern Time. Members of the Company's management team will provide an overview of the Company's vision, strategy, growth initiatives, business trends, products and technology as well as its financial goals. Evolv Technology Investor Day 2026 will be webcast live at http://ir.evolvtechnology.com. About Evolv Technology Evolv (NASDAQ:EVLV) is designed to transform human security by helping organizations detect p

    6/1/26 9:00:00 AM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Bank of America Stadium Reports Efficient Game-Day Operations Using Evolv Technology

    Findings highlight high-throughput fan entry and real-time operational visibility supporting Carolina Panthers game-day operations Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to create safer experiences, shares new insights into the operational impact at Bank of America Stadium driven by ongoing use of Evolv Express® for efficient, high-volume fan entry security screening. As an early adopter of Evolv Express, purchasing Gen1 in 2021, the stadium recently announced their renewal and upgrade to Evolv Express Gen2 and the addition of Evolv eXpedite™ bag screening for employee entrances. Bank of America Stadi

    5/13/26 8:05:00 AM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Evolv Technology to Host Investor Day on June 9, 2026

    Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced that it will host Evolv Technology Investor Day 2026 on Tuesday, June 9, 2026 from 9:00 a.m. to 12:00 p.m. Eastern Time. Members of the Company's management team will provide an overview of the Company's vision, strategy, growth initiatives, business trends, products and technology as well as its financial goals. Evolv Technology Investor Day 2026 will be webcast live at http://ir.evolvtechnology.com. About Evolv Technology Evolv (NASDAQ:EVLV) is designed to transform human security by helping organizations detect p

    5/13/26 8:00:00 AM ET
    $EVLV
    Computer peripheral equipment
    Technology

    $EVLV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Evolv Technologies Holdings upgraded by Lake Street with a new price target

    Lake Street upgraded Evolv Technologies Holdings from Hold to Buy and set a new price target of $9.00

    8/15/25 8:30:18 AM ET
    $EVLV
    Computer peripheral equipment
    Technology

    TD Cowen resumed coverage on Evolv Technologies Holdings with a new price target

    TD Cowen resumed coverage of Evolv Technologies Holdings with a rating of Buy and set a new price target of $10.00

    8/15/25 8:18:59 AM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Evolv Technologies Holdings upgraded by Northland Capital with a new price target

    Northland Capital upgraded Evolv Technologies Holdings from Market Perform to Outperform and set a new price target of $7.50

    5/21/25 8:40:06 AM ET
    $EVLV
    Computer peripheral equipment
    Technology

    $EVLV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Revenue Officer Marshall Robert E bought $42,420 worth of shares (7,000 units at $6.06) (SEC Form 4)

    4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

    11/25/25 4:03:38 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Director Charlton Kevin M. bought $85,196 worth of shares (15,000 units at $5.68) (SEC Form 4)

    4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

    11/21/25 4:39:17 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Director Shapiro Richard A bought $278,126 worth of shares (46,300 units at $6.01), increasing direct ownership by 133% to 52,515 units (SEC Form 4)

    4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

    11/20/25 4:20:48 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    $EVLV
    SEC Filings

    View All

    SEC Form SD filed by Evolv Technologies Holdings Inc.

    SD - Evolv Technologies Holdings, Inc. (0001805385) (Filer)

    6/1/26 4:19:12 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Evolv Technologies Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Evolv Technologies Holdings, Inc. (0001805385) (Filer)

    5/13/26 3:12:56 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    SEC Form 10-Q filed by Evolv Technologies Holdings Inc.

    10-Q - Evolv Technologies Holdings, Inc. (0001805385) (Filer)

    5/12/26 4:15:17 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    $EVLV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Revenue Officer Marshall Robert E converted options into 136,363 shares and sold $425,159 worth of shares (62,067 units at $6.85), increasing direct ownership by 1,061% to 81,296 units (SEC Form 4) (tax liability)

    4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

    6/3/26 4:09:30 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Director Ellenbogen Michael exercised 80,745 shares at a strike of $0.24 and sold $454,594 worth of shares (80,745 units at $5.63) as part of a pre-agreed trading plan (SEC Form 4)

    4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

    5/18/26 4:03:30 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Chief Financial Officer Kutsor George C converted options into 138,888 shares and sold $374,027 worth of shares (51,448 units at $7.27) (SEC Form 4) to satisfy withholding tax

    4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

    5/5/26 4:37:44 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    $EVLV
    Leadership Updates

    Live Leadership Updates

    View All

    Evolv Technology Announces the Appointment of Henrik Kühl as a New Independent Director

    – Long-Time Member of the Board of Directors and Early Venture Capitalist Bilal Zuberi Resigns from Board – Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to create safer experiences, today announced the appointment of Mr. Henrik Kühl, age 46, to its Board of Directors ("Board") effective February 12, 2026. Kühl will also serve on the Board's Audit Committee. The Board affirmatively determined that Kühl is independent and an audit committee financial expert as that term is defined by applicable Securities and Exchange Commission regulations. Kühl is an accomplished leader with over 25 years of experience in c

    2/12/26 8:00:00 AM ET
    $AXON
    $EVLV
    Ordnance And Accessories
    Industrials
    Computer peripheral equipment
    Technology

    TransAct Appoints Dana Loof as Chief Marketing Officer to Accelerate Growth and Platform Expansion

    TransAct Technologies Incorporated (NASDAQ:TACT) ("TransAct" or the "Company"), a global leader in software-driven technology and integrated printing solutions, today announced the appointment of Dana Loof as Chief Marketing Officer. Ms. Loof will lead TransAct's global marketing organization, with a mandate to strengthen brand leadership, sharpen go-to-market execution, and accelerate adoption of the Company's growing technology portfolio. Ms. Loof has a 30-year track record leading high-growth technology companies, where she has been responsible for global marketing strategy, brand strategy and positioning, category building, revenue generation, and customer engagement initiatives. In h

    1/20/26 4:05:00 PM ET
    $EVLV
    $TACT
    Computer peripheral equipment
    Technology

    Evolv Extends Partnership with New England Patriots, New England Revolution, and Gillette Stadium

    Extension of original 2021 agreement includes expansion of Evolv Express subscription, and official partnership designations Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to create safer experiences, today announced that it renewed its partnership with Gillette Stadium, home of the New England Patriots and New England Revolution. The renewal, which extends a partnership initiated in 2021, increases the number of entry points at which Evolv Express® security screening will be used. All members of the public entering the stadium for football games, soccer matches, concerts, and other events will pass through an

    9/16/25 12:00:00 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    $EVLV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Evolv Technologies Holdings Inc.

    SC 13G/A - Evolv Technologies Holdings, Inc. (0001805385) (Subject)

    12/12/24 3:21:41 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Amendment: SEC Form SC 13G/A filed by Evolv Technologies Holdings Inc.

    SC 13G/A - Evolv Technologies Holdings, Inc. (0001805385) (Subject)

    11/12/24 2:31:40 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Amendment: SEC Form SC 13G/A filed by Evolv Technologies Holdings Inc.

    SC 13G/A - Evolv Technologies Holdings, Inc. (0001805385) (Subject)

    11/7/24 4:31:46 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    $EVLV
    Financials

    Live finance-specific insights

    View All

    Evolv Technology Reports First Quarter Financial Results

    — Company Raises Outlook for 2026 — Q1'26 Revenue of $46.3 million, up 45% year-over-year Q1'26 Ending ARR1 of $127.3 million, up 20% year-over-year Q1'26 Net Loss of $(5.0) million, with Net Profit Margin of (10.8)% Q1'26 Adjusted EBITDA2 of $3.9 million, with Adjusted EBITDA Margin2 of 8.5% Evolv Technologies Holdings, Inc (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced financial results for the quarter ended March 31, 2026. "Our first quarter results reflect our progress in building a disciplined and predictable business," said John Kedzierski, President and Chief Executive Offi

    5/12/26 4:05:00 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Evolv Technology to Release First Quarter Financial Results on May 12, 2026

    Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced that the Company will release financial results for the first quarter of 2026 on Tuesday, May 12, 2026, after the market closes. Members of the Company's management team plan to host a live webcast at 4:30 p.m. Eastern Time on that day to discuss the financial results as well as management's outlook for the business. The conference call will be webcast live at http://ir.evolvtechnology.com. About Evolv Technology Evolv (NASDAQ:EVLV) is designed to transform human security by helping organizations detect potential th

    4/8/26 8:00:00 AM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Evolv Technology Reports Fourth Quarter Financial Results

    — Company Raises Outlook for 2026 —  Q4'25 Revenue of $38.5 million, up 32% year-over-year Q4'25 Ending ARR1 of $120.5 million, up 21% year-over-year Q4'25 Net Income of $10.9 million, with Net Profit Margin of 28% Q4'25 Adjusted EBITDA2 of $1.8 million, with Adjusted EBITDA Margin2 of 5% Q4'25 Ending Cash, Cash Equivalents and Marketable Securities of $69.0 million, up $12.8 million sequentially Evolv Technologies Holdings, Inc (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced financial results for the year ended December 31, 2025. "We are pleased to be reporting solid fourth qua

    3/10/26 4:05:00 PM ET
    $EVLV
    Computer peripheral equipment
    Technology